For citations:

Dyakov I.N., Zyryanov S.K. The pharmacoeconomic comparison of the fixed insulin glargine and lixisenatide combination with insulin degludec family in type 2 diabetes mellitus. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2020;(5):4-14. (In Russ.) https://doi.org/10.37489/2588-0519-2020-5-4-14